Reltecimod
| CAS No. | 1447799-33-8 | Cat. No. | BCP24918 |
| Name | Reltecimod | ||
| Synonyms | AB-103; P-2TA; AB103; P2TA; NSC-37096; | ||
| Formula | C46H72N10O15S | M. Wt | 1037.2 |
| Description | Reltecimod is a T-cell-specific surface glycoprotein CD28 (TP44) antagonist. Reltecimod has beneficial effects against different bacterial infections, their exotoxins and endotoxins, and ionizing radiation. Reltecimod modulates the inflammatory response by targeting and attenuating the critical CD28/B7-2 co-stimulatory pathway, without inhibiting it. Reltecimod can be used to research necrotizing soft-tissue infections (NSTIs). | ||
| Pathways | Microbiology/Virology | ||
| Targets | Antibiotic | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.